Annotation Detail for MYO16
Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| P00044 | Nicotinic acetylcholine receptor signaling pathway |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MYO16 mRNA | affects expression | 16483693
|
| D011374 |
Progesterone |
Progesterone results in increased expression of MYO16 mRNA | increases expression | 17404688
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.44 | 18287403 |
| MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
6.41 | 17868700 |
| MESH:D001930 |
Brain Injuries |
|
Progesterone |
5.02 | 15665606 15845082 15380490 |
| MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.40 | 17614352 15562024 16175315 |
| MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
5.26 | 17187935 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.45 | 17692515 |
| MESH:D004715 |
Endometriosis |
|
Progesterone |
4.27 | 16134523 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
5.17 | 15869954 |
| MESH:D007249 |
Inflammation |
|
Progesterone |
2.81 | 15869954 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
3.15 | 11408345 17203775 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.63 | 16525653 17393432 |
| MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.98 | 18045962 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
5.17 | 16503802 15862959 |
Related Diseases/Disorders